Understanding Perspectives of Patients With Hidradenitis Suppurativa in an Era of Novel Treatment Options

Don't miss this unique and engaging opportunity to hear directly from a patient living with hidradenitis suppurativa (HS) as she shares her treatment journey. Along the way, answer questions about how you would respond to this real-world clinical scenario and see how your choices compare with those of other healthcare professionals.

You will also learn about insights into the pathogenesis of HS and novel treatment targets through an innovative whiteboard animation. Additionally, the latest data for new and emerging targeted medications for HS will be reviewed. A point-of-care tool to facilitate therapy selection for your HS patients will be available for download when you are finished.

• Discuss the pathogenesis and disease progression of HS, including the role of inflammatory pathways and mediators that serve as targets for novel treatments
• Evaluate targeted therapies for patients with HS based on mechanism of action, route of administration, efficacy, and safety
• Develop comprehensive management plans for patients with HS based on the latest evidence, guidelines, disease severity, patient preference, and presence of comorbidities

• 0.5 CME/CE for Physicians (ACCME)
• 0.5 CME/CE for Physician Assistants (AAPA)
• 0.5 CH/CE for Nurse Practitioners (AANP)
• 0.5 CPE for Pharmacists (ACPE + NABP)
• 0.5 CNE for Nurses (ANCC)

This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by an educational grant from Novartis.